About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
(C) 2024 MINKABU THE INFONOID, Inc.

Oncolys BioPharma Inc.(4588) Summary

4588
TSE Growth
Oncolys BioPharma Inc.
510
JPY
+4
(+0.79%)
Dec 23, 10:23 am JST
3.28
USD
Dec 22, 7:33 pm EST
Result
PTS
outside of trading hours
510.7
Dec 23, 10:22 am JST
Summary Chart Historical News Financial Result
PER
PBR
6.49
Yield
ー%
Margin Trading Ratio
1,106.35
Stock Price
Dec 23, 2024
Opening Dec 23, 9:00 am
507 JPY 3.23 USD
Previous Close Dec 20
506 JPY 3.22 USD
High Dec 23, 9:32 am
515 JPY 3.29 USD
Low Dec 23, 9:03 am
495 JPY 3.16 USD
Volume
514,200
Trading Value
0.26B JPY 1.12M USD
VWAP
507.35 JPY 3.24 USD
Minimum Trading Value
51,000 JPY 328 USD
Market Cap
0.01T JPY 0.08B USD
Number of Trades
729
Liquidity & Number of Trades
As of Dec 23, 2024
Liquidity
Slightly High
1-Year Average
928
1-Year High Nov 12, 2024
10,905
Margin Trading
Date Short Interest Long Margin Positions Ratio
Dec 13, 2024 500 4,087,700 8175.40
Dec 6, 2024 300 4,070,700 13569.00
Nov 29, 2024 0 3,905,600
Nov 22, 2024 3,400 3,761,600 1106.35
Nov 15, 2024 0 3,367,400
Company Profile
Oncolys BioPharma Inc. is a drug discovery venture focusing on rare cancers and severe infectious diseases, utilizing proprietary virus technology.
Sector
Pharmaceuticals